weSRCH.com an on-line symposium for professionals; members can read and post technical papers, upload free press releases, submit press releases in High Tech, Med Tech, and Green Tech. It fosters innovation and professional development through publication.
Wednesday, February 6, 2013
Dapoxetine and PDE5i in PE
Dapoxetine and PDE5i in PE - Dapoxitine only approved in some countries including Korea, Rapid acting & short half-life SSRI with a pharmacokinetic profile suggesting a role as on-demand treatment for PE.